Date of Award
Ph.D. in Counselor Education
Leadership and Counselor Education
Richard S. Balkin
Alan S. Lenz
Stephanie L. Lusk
A number of authors have published articles that assert the efficacy of neurofeedback (NFB) in the treatment of people with anxious symptomatology. Despite this, many insurance companies identify NFB as experimental, which prohibits individuals from utilizing benefits to obtain this therapeutic treatment. In order to examine these discrepancies, the present meta-analyses were conducted and guided by research questions designed to examine the overall effectiveness of NFB, the impact of participant characteristics, and identify the if there is a significant difference in anxiety-spectrum outcomes. Twenty-six trials were divided based on design (14 single group [SG]; 12 between group [BG]) and analyzed in separate meta-analyses. Overall, results indicate that anxiety-spectrum self-report assessments reduced by nearly one (SG SDM = -0.94; BG g= -0.87) standard deviation unit with relatively small degrees of bias. Limitations and future directions are reported.
Russo, Gordon Michael, "The Efficacy of Neurofeedback in the Treatment of Individuals with Anxiety-Spectrum Disorders: A Meta-Analysis" (2021). Electronic Theses and Dissertations. 2050.